Amisulpride
Showing 26 - 50 of 85
Schizophrenia Trial in Germany (Cannabidiol as add-on, Placebo as add-on)
Active, not recruiting
- Schizophrenia
- Cannabidiol as add-on
- Placebo as add-on
-
Mannheim, BW, Germany
- +5 more
Feb 23, 2021
First-episode Schizophrenic Patients
Completed
- Schizophrenia
- Metabolic Syndrome
- antipsychotic medications
- +2 more
-
Changsha, Hunan, ChinaMental Health Institute of 2nd Xiangya Hospital,CSU
Aug 10, 2021
Schizophrenia Trial in Shanghai (acupuncture, Amisulpride)
Unknown status
- Schizophrenia
- acupuncture
- Amisulpride
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jan 11, 2019
Based on French National Health Insurance Database in Psychotic
Not yet recruiting
- Psychotic Disorders
- No Intervention
- (no location specified)
Nov 21, 2022
Postoperative Nausea and Vomiting Trial in France, Germany, United States (APD421, Placebo)
Patients With Schizophrenia Trial (Therapeutic Drug Monitoring (TDM) and Pharmacogenetics (PG))
Not yet recruiting
- Patients With Schizophrenia
- Therapeutic Drug Monitoring (TDM) and Pharmacogenetics (PG)
- (no location specified)
May 1, 2023
Schizophrenia Trial in Germany (Maintenance treatment, Intermittent treatment)
Terminated
- Schizophrenia
- Maintenance treatment
- Intermittent treatment
-
Aachen, NRW, Germany
- +10 more
Nov 23, 2020
Postoperative Nausea and Vomiting Trial in France, Germany, United States (APD421, Placebo)
Common Mental Disorder Trial in Changsha (Antipsychotic drugs, Mood stabilizer, Paroxetine)
Recruiting
- Common Mental Disorder
- Antipsychotic drugs
- +2 more
-
Changsha, ChinaThe Second Xiangya Hospital of Central South University
Aug 10, 2020
Schizophrenia Trial in Shanghai (Olanzapine, Risperidone, Aripiprazole)
Unknown status
- Schizophrenia
- Olanzapine
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center, Shanghai Jiao Tong University Sch
Jul 30, 2018
Schizophrenia, Schizophrenia and Disorders With Psychotic Features, Schizoaffective Disorders Trial in Munich (Olanzapine,
Completed
- Schizophrenia
- +2 more
- Olanzapine
- +18 more
-
Munich, Bavaria, GermanyPsychiatrische Klinik und Poliklinik fuer Psychiatrie und Psycho
Oct 10, 2018
MDD (MDD) Trial in Belmont (amisulpride, )
Completed
- Major Depressive Disorder (MDD)
- amisulpride
- placebo
-
Belmont, MassachusettsMcLean Hospital
Apr 25, 2018
CINV Trial in Odense (Ondansetron, Placebo, Dexamethasone)
Chronic Fatigue Syndromes Trial in Shanghai (Yan Nian Jiu Zhuan Fa)
Recruiting
- Chronic Fatigue Syndromes
- Yan Nian Jiu Zhuan Fa
-
Shanghai, ChinaShanghai University of Traditional Chinese Medicine
Mar 16, 2021
MDD (MDD), History of Childhood Sexual Abuse (CSA) Trial in Belmont, Boston (Amisulpride, Placebo)
Completed
- Major Depressive Disorder (MDD)
- History of Childhood Sexual Abuse (CSA)
- Amisulpride
- Placebo
-
Belmont, Massachusetts
- +1 more
May 16, 2018
Schizophrenia Trial in Augusta (Tocilizumab)
Completed
- Schizophrenia
-
Augusta, GeorgiaGeorgia Health Sciences University
Jul 27, 2021
Schizophrenia Trial in Mannheim, Cologne (Cannabidiol CR, Cannabidiol, Amisulpride)
Completed
- Schizophrenia
- Cannabidiol CR
- +6 more
-
Mannheim, BW, Germany
- +1 more
Mar 7, 2018
Atypical Antipsychotics Long-term Treatment Schizophrenia
Recruiting
- Schizophrenia
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 13, 2021
Schizophrenia, Psychotic Disorders Trial in Augusta (Siltuximab, normal saline)
Recruiting
- Schizophrenia
- Psychotic Disorders
- Siltuximab
- normal saline
-
Augusta, GeorgiaAugusta University
Jul 27, 2021
Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder Trial in Worldwide (Amisulpride open label, 6-week
Completed
- Schizophrenia
- +2 more
- Amisulpride open label
- +4 more
-
Melbourne, Australia
- +25 more
May 14, 2018
Inhibition (Psychology), Schizophrenia, Medication Adherence Trial in 'Afula (PPI monitoring device protocol, Questionnaires)
Completed
- Inhibition (Psychology)
- +2 more
- PPI monitoring device protocol
- Questionnaires
-
'Afula, IsraelHaemek Medical Center
Feb 12, 2020